biomarkers of chronic graft-versus-host disease MICA-129 genotype, soluble MICA, and anti-MICA antibodies as

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.

  2009cited by this paper
• Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.

  2009cited by this paper
• Oxidative Stress Mediates a Reduced Expression of the Activating Receptor NKG2D in NK Cells from End-Stage Renal Disease Patients1

  2009cited by this paper
• Role of major histocompatibility complex class I‐related molecules A*A5·1 allele in ulcerative colitis in Chinese patients

  2009cited by this paper
• Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.

  2009cited by this paper
• Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

  2008cited by this paper
• An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation1

  2008cited by this paper
• MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

  2008cited by this paper
• Tumor-associated MICA is shed by ADAM proteases.

  2008cited by this paper
• Chronic GVHD as an autoimmune disease.

  2008cited by this paper
• Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

  2008cited by this paper
• Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.

  2007cited by this paper
• The management and outcome of chronic graft‐versus‐host disease

  2007cited by this paper
• Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands

  2007cited by this paper
• Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

  2007cited by this paper
• The Pathophysiology of Graft‐Versus‐Host Disease

  2007cited by this paper
• In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer

  2007cited by this paper
• Promiscuity and the single receptor: NKG2D

  2007cited by this paper
• Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft‐versus‐host disease after HLA identical sibling bone marrow transplants

  2007cited by this paper
• Association of autoimmune disease‐related gene polymorphisms with chronic graft‐versus‐host disease

  2007cited by this paper
• Non-HLA gene polymorphisms and the outcome of allogeneic hemato-poietic stem cell transplantation.

  2006cited by this paper
• The Predictive Value of Soluble Major Histocompatibility Complex Class I Chain-Related Molecule A (MICA) Levels on Heart Allograft Rejection

  2006cited by this paper
• Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.

  2006cited by this paper
• Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations.

  2006cited by this paper
• Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

  2006cited by this paper
• Chronic graft-versus-host disease

  2006cited by this paper
• How NKG2D ligands trigger autoimmunity?

  2006cited by this paper
• Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.

  2006cited by this paper
• Soluble MICA in malignant diseases

  2006cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism.

  2005cited by this paper
• MIC and other NKG2D ligands: from none to too many.

  2005cited by this paper
• Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non‐relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA‐matched sibling donors

  2005cited by this paper
• Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

  2005cited by this paper
• Emergent autoimmunity in graft-versus-host disease.

  2005cited by this paper
• Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

  2005cited by this paper
• A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

  2004cited by this paper
• NKG2D blockade prevents autoimmune diabetes in NOD mice.

  2004cited by this paper
• Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

  2003cited by this paper
• Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.

  2003cited by this paper
• Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

  2002cited by this paper
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

  2002cited by this paper
• Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation.

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

  2001cited by this paper
• MIC genes: from genetics to biology.

  2000cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

  1998cited by this paper
• Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.

  1995cited by this paper
• Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.

  1994cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper

• No citing papers are available for this paper.